IP Verse

Mrna Therapy For Argininosuccinate Synthetase Deficiency - EP3060303

PATENT ANALYSIS

Patent Details

Grant Date: Nov 14, 2018
Company: SHIRE HUMAN GENETIC THERAPIES, INC.
Oppositions

More patents of Shire Human Genetic Therapies, Inc.

Want to monitor this patent?

Feel free to send us a message here and we will get back to you